MediciNova vs SciSparc
MNOV and SPRC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MNOV and SPRC compare
MediciNova keeps more of each dollar of sales as profit, with a net margin of −1168% compared with −1423% at SciSparc.
MediciNova scores higher on the StockData Score (7 against 3 for SciSparc), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MNOV | SPRC |
|---|---|---|
| Size and price | ||
| Market cap | $69.4M | – |
| Share price | $1.41 | $0.398 |
| Change, 1 year | 0.00% | −98.4% |
| Change, 5 years | −56.1% | −100.0% |
| Beta (5Y) | 0.39 | 0.33 |
| Employees | 6 | 3 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 75.4× | – |
| P/B | 1.9× | – |
| FCF yield | −13.1% | – |
| Growth | ||
| Revenue growth (TTM) | – | −34.5% |
| EPS growth (TTM) | – | −51.9% |
| EPS growth, 5Y average | – | 36.4% |
| Profitability | ||
| Gross margin | – | 73.7% |
| Operating margin | −1287% | −978% (better) |
| Net margin | −1168% (better) | −1423% |
| FCF margin | −991% | – |
| Return on equity | −25.6% (better) | −770% |
| Return on invested capital | −76.6% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.09 (better) |
| Interest coverage | – | −1.0× |
| Current ratio | 8.75 (better) | 0.87 |
| Altman Z-score | −2.46 | – |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 10.5% | – |
| Held by insiders | 12.8% | 15.6% |
| Insider net buying, 12 months | −$1.7M | −$4.6K (better) |
| Short interest, % of float | 0.66% | 22.5% |
Go deeper
- MNOV stock overview
- MNOV income statement
- MNOV valuation and score
- SPRC stock overview
- SPRC income statement
- SPRC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.